Obesity-dependent increase in RalA activity disrupts mitochondrial dynamics in white adipocytes.
Wenmin XiaPreethi VeeragandhamYu CaoYayun XuTorrey RhyneJiaxin QianChao-Wei HungPeng ZhaoYing JonesHui GaoChristopher LiddleRuth T YuMichael DownesRonald M EvansMikael RydénMartin WabitschShannon ReillyJianfeng HuangAlan R SaltielPublished in: Research square (2023)
Mitochondrial dysfunction is a characteristic trait of human and rodent obesity, insulin resistance, and fatty liver disease. Here we report that mitochondria undergo fragmentation and reduced oxidative capacity specifically in inguinal white adipose tissue after feeding mice high fat diet (HFD) by a process dependent on the small GTPase RalA. RalA expression and activity are increased in white adipocytes from mice fed HFD. Targeted deletion of Rala in white adipocytes prevents the obesity-induced fragmentation of mitochondria and produces mice resistant to HFD-induced weight gain via increased fatty acid oxidation. As a result, these mice also exhibit improved glucose tolerance and liver function. In vitro mechanistic studies revealed that RalA suppresses mitochondrial oxidative function in adipocytes by increasing fission through reversing the protein kinase A-catalyzed inhibitory Ser 637 phosphorylation of the mitochondrial fission protein Drp1. Active RalA recruits protein phosphatase 2A (PP2Aa) to specifically dephosphorylate this inhibitory site on Drp1, activating the protein, thus increasing mitochondrial fission. Adipose tissue expression of the human homolog of Drp1, DNML1 , is positively correlated with obesity and insulin resistance in patients. Thus, chronic activation of RalA plays a key role in repressing energy expenditure in obese adipose tissue by shifting the balance of mitochondrial dynamics towards excessive fission, contributing to weight gain and related metabolic dysfunction.
Keyphrases
- insulin resistance
- high fat diet
- high fat diet induced
- adipose tissue
- weight gain
- oxidative stress
- body mass index
- metabolic syndrome
- polycystic ovary syndrome
- birth weight
- protein kinase
- skeletal muscle
- endothelial cells
- weight loss
- type diabetes
- diabetic rats
- fatty acid
- binding protein
- high glucose
- poor prognosis
- end stage renal disease
- signaling pathway
- protein protein
- drug induced
- chronic kidney disease
- newly diagnosed
- ejection fraction
- long non coding rna
- cell death
- peritoneal dialysis
- dna methylation
- induced pluripotent stem cells
- prostate cancer